2fsz: Difference between revisions
From Proteopedia
Jump to navigationJump to search
New page: left|200px<br /> <applet load="2fsz" size="450" color="white" frame="true" align="right" spinBox="true" caption="2fsz, resolution 2.200Å" /> '''A second binding s... |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:2fsz.gif|left|200px]]<br /> | [[Image:2fsz.gif|left|200px]]<br /><applet load="2fsz" size="350" color="white" frame="true" align="right" spinBox="true" | ||
<applet load="2fsz" size=" | |||
caption="2fsz, resolution 2.200Å" /> | caption="2fsz, resolution 2.200Å" /> | ||
'''A second binding site for hydroxytamoxifen within the coactivator-binding groove of estrogen receptor beta'''<br /> | '''A second binding site for hydroxytamoxifen within the coactivator-binding groove of estrogen receptor beta'''<br /> | ||
==Overview== | ==Overview== | ||
Evidence is presented that the estrogen antagonist 4-hydroxytamoxifen (HT) | Evidence is presented that the estrogen antagonist 4-hydroxytamoxifen (HT) can occupy not only the core binding pocket within the ligand-binding domain of estrogen receptor (ER) beta but also a second site on its surface. The crystal structure of the ligand-binding domain (LBD) associated with HT was determined to 2.2 A and revealed two molecules of HT bound to the protein. One was located in the consensus ligand-binding pocket, whereas the other bound to a site that overlaps with the hydrophobic groove of the coactivator recognition surface. Relative to the ERalpha-tamoxifen structure, helix 12 has been displaced from the coactivator recognition surface and occupies a unique position. Although it has been demonstrated that association of the antagonist with the core ligand-binding pocket is sufficient to induce an antagonist ligand-binding domain conformation, this structure suggests that small molecules may directly antagonize receptor-coactivator interactions. These results provide a direct demonstration of two binding sites for HT in ERbeta, as has been previously suggested for ERalpha by using biochemical methods, and represent a crystal structure of a small nonpeptide molecule occupying the coactivator recognition site. | ||
==About this Structure== | ==About this Structure== | ||
2FSZ is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with OHT as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http:// | 2FSZ is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=OHT:'>OHT</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2FSZ OCA]. | ||
==Reference== | ==Reference== | ||
| Line 18: | Line 17: | ||
[[Category: nuclear hormone binding domain]] | [[Category: nuclear hormone binding domain]] | ||
''Page seeded by [http:// | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 17:24:51 2008'' | ||